Correlation of surrogate markers of Gaucher disease. Implications for long-term follow up of enzyme replacement therapy.
about
Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapyIncreased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study.Clinical and genetic characteristics of Gaucher disease according to phenotypic subgroups.A case of adult type 1 Gaucher disease complicated by temporal intestinal hemorrhage.Evaluation of estimation methods and power of tests of discrete covariates in repeated time-to-event parametric models: application to Gaucher patients treated by imiglucerase.Modeling changes in biomarkers in Gaucher disease patients receiving enzyme replacement therapy using a pathophysiological model.Bone events and evolution of biologic markers in Gaucher disease before and during treatment.Successful screening for Gaucher disease in a high-prevalence population in tabuleiro do Norte (northeastern Brazil): a cross-sectional studyLaboratory and genetic evaluation of Gaucher disease.Beyond osteogenesis imperfecta: Causes of fractures during infancy and childhood.Modelling long-term evolution of chitotriosidase in non-neuronopathic Gaucher disease.Skeletal involvement in Gaucher disease: An observational multicenter study of prognostic factors in the Argentine Gaucher disease patients.Allele frequency of a 24 bp duplication in exon 10 of the CHIT1 gene in the general Korean population and in Korean patients with Gaucher disease.Aggregation of red blood cells in patients with Gaucher disease.
P2860
Q28067032-B299E6B5-25D6-4DCA-A5A0-666644A2A1E5Q30820579-0A12B07A-BC4C-416F-A94B-2F792C4B762DQ33399972-2DA5C33B-D0CD-44C5-8F2E-BB74E36ED763Q33410227-1FD9057E-99BB-42BE-87C8-7EFC9723808BQ33574132-8084F88E-E16A-4C26-925A-FE019C3B2AD1Q33891532-98111B6A-7FD8-428B-ADA7-34ED165CF945Q34153094-C373E003-8791-4C04-84DB-EDA523C80339Q36433244-E0A8B0D6-9483-41E8-8114-AFDD36003991Q37780488-AEDBCF7E-8420-4E17-9837-E9AA7EDAFD12Q38623995-93763FF1-518E-4179-AB05-D8117B5184AEQ38893633-D551F2F5-ABCE-45A7-A19A-D68294383FA7Q40649689-EE17EBD7-22B9-4F54-BA84-124B96B885C7Q50459554-936AA4A5-3165-4151-AEA9-E9E072860B6BQ50729317-4304A9BF-D26C-4B6D-BE1E-8D533F41C69C
P2860
Correlation of surrogate markers of Gaucher disease. Implications for long-term follow up of enzyme replacement therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Correlation of surrogate marke ...... of enzyme replacement therapy.
@en
Correlation of surrogate marke ...... of enzyme replacement therapy.
@nl
type
label
Correlation of surrogate marke ...... of enzyme replacement therapy.
@en
Correlation of surrogate marke ...... of enzyme replacement therapy.
@nl
prefLabel
Correlation of surrogate marke ...... of enzyme replacement therapy.
@en
Correlation of surrogate marke ...... of enzyme replacement therapy.
@nl
P2093
P1433
P1476
Correlation of surrogate marke ...... of enzyme replacement therapy.
@en
P2093
Erin O'Rourke
Howard Wessel
John A Barranger
Mario A Cabrera-Salazar
Nadene Henderson
P304
P356
10.1016/J.CCCN.2004.02.018
P577
2004-06-01T00:00:00Z